These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
132 related articles for article (PubMed ID: 12693402)
21. Outcome in the real-world of coronary high-risk intervention with drug-eluting stents (ORCHID) -- a single-center study comparing Cypher sirolimus-eluting with Taxus paclitaxel-eluting stents. Kumar S; Suresh V; Prendergast BD; Brooks NH; Wicks P; Levy RD; Ray SG; Bennett DH; Lee HS Catheter Cardiovasc Interv; 2006 Nov; 68(5):663-8. PubMed ID: 17034063 [TBL] [Abstract][Full Text] [Related]
22. Choosing a drug-eluting stent: a comparison between CYPHER and TAXUS. Perin EC Rev Cardiovasc Med; 2005; 6 Suppl 1():S13-21. PubMed ID: 15665793 [TBL] [Abstract][Full Text] [Related]
23. Safety and efficacy of drug-eluting stents. Williams DO; Kereiakes DJ Rev Cardiovasc Med; 2005; 6 Suppl 1():S22-30. PubMed ID: 15665794 [TBL] [Abstract][Full Text] [Related]
24. Effectiveness of sirolimus-eluting stent implantation for recurrent in-stent restenosis after brachytherapy. Saia F; Lemos PA; Sianos G; Degertekin M; Lee CH; Arampatzis CA; Hoye A; Tanabe K; Regar E; van der Giessen WJ; Smits PC; de Feyter P; Ligthart J; van Domburg RT; Serruys PW Am J Cardiol; 2003 Jul; 92(2):200-3. PubMed ID: 12860224 [No Abstract] [Full Text] [Related]
25. Day in and day out. Holmes DR Catheter Cardiovasc Interv; 2004 May; 62(1):30. PubMed ID: 15103596 [No Abstract] [Full Text] [Related]
26. [Safety and current indications during "real life" use of sirolimus-eluting coronary stents in Germany. Results from the prospective multicenter German Cypher Registry]. Zahn R; Hamm CW; Zeymer U; Schneider S; Nienaber CA; Richardt G; Kelm M; Levenson B; Bonzel T; Tebbe U; Schöbel WA; Sabin G; Senges J; Herz; 2004 Mar; 29(2):181-6. PubMed ID: 15057439 [TBL] [Abstract][Full Text] [Related]
27. Acute and intermediate-term procedural results using cypher stenting to treat multi-vessel coronary artery disease. Kornowski R; Vaknin-Assa H; Assali A; Fuchs S Int J Cardiovasc Intervent; 2005; 7(3):122-5. PubMed ID: 16243732 [TBL] [Abstract][Full Text] [Related]
28. The future of CART in the era of drug eluting stents: "It's not over until it's over". Counterpoint. Tripuraneni P Brachytherapy; 2003; 2(2):74-6. PubMed ID: 15062143 [No Abstract] [Full Text] [Related]
29. Double jeopardy: balance between bleeding and stent thrombosis with prolonged dual antiplatelet therapy after drug-eluting stent implantation. Yan BP; Gurvitch R; Ajani AE Cardiovasc Revasc Med; 2006; 7(3):155-8. PubMed ID: 16945822 [TBL] [Abstract][Full Text] [Related]
30. [Drug-eluting stents: breakthrough or time bomb]. Lüscher TF; Silber S Herz; 2007 Jun; 32(4):265-7. PubMed ID: 17607531 [No Abstract] [Full Text] [Related]
31. Living the dream of no restenosis. Teirstein PS Circulation; 2001 Oct; 104(17):1996-8. PubMed ID: 11673334 [No Abstract] [Full Text] [Related]
32. [The Nordic Bifurcation Study. Randomized study on the question of optimal stenting technique for bifurcating stenosis]. Herz; 2006 May; 31(3):257. PubMed ID: 17431944 [No Abstract] [Full Text] [Related]
33. The future of coronary artery radiation therapy--"the CART before the (unbridled) horse!". Point. Devlin PM Brachytherapy; 2003; 2(2):73-4. PubMed ID: 15062142 [No Abstract] [Full Text] [Related]
34. Angioscopic findings after drug-eluting stent implantation. Takano M; Mizuno K Herz; 2007 Jun; 32(4):281-6. PubMed ID: 17607534 [TBL] [Abstract][Full Text] [Related]
35. Stent-based delivery of ABT-578 via a phosphorylcholine surface coating reduces neointimal formation in the porcine coronary model. Collingwood R; Gibson L; Sedlik S; Virmani R; Carter AJ Catheter Cardiovasc Interv; 2005 Jun; 65(2):227-32. PubMed ID: 15900559 [TBL] [Abstract][Full Text] [Related]
37. Molecular basis of restenosis and drug-eluting stents. Costa MA; Simon DI Circulation; 2005 May; 111(17):2257-73. PubMed ID: 15867193 [No Abstract] [Full Text] [Related]